65 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
740-10 “Accounting for Income Taxes”, which requires the use of the liability method of accounting for income taxes, whereby deferred tax asset … and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
), are intended to be granted pursuant to the capital gains track of Section 102 of the Israeli Income Tax Ordinance [New Version] 5721-1961.
Each of our … agreements to be entered into with each of them, and shall be granted pursuant to the capital gains track of Section 102 of the Israeli Income Tax
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
-10 “Accounting for Income Taxes”, which requires the use of the liability method of accounting for income taxes, whereby deferred tax asset … and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
.
(ff) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse … and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental
424B5
iildnb5xi9 elqti5pk9
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
m6ln5r
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
F-3
g5bo2nv8 ww
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
ntfdjywvamt pr
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-1.1
a0r6iz6xhm69iu0o4as
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
gvq mwigafc5
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
q3f 9gjokl6nd8cpdzz
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
b4h fg4wz
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.2
x74bbn6fn9dv0jeh
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-10.1
gtdn0as8gq7y3ddt
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
mye v2mi98t18sa9
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K/A
EX-99.2
a2e5zb70cda0oito
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.2
h2v dd10r
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm